carvedilol has been researched along with Arrhythmogenic Right Ventricular Dysplasia in 1 studies
Arrhythmogenic Right Ventricular Dysplasia: A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiroi, Y | 1 |
| Fujiu, K | 1 |
| Komatsu, S | 1 |
| Sonoda, M | 1 |
| Sakomura, Y | 1 |
| Imai, Y | 1 |
| Oishi, Y | 1 |
| Nakamura, F | 1 |
| Ajiki, K | 1 |
| Hayami, N | 1 |
| Murakawa, Y | 1 |
| Ohno, M | 1 |
| Hirata, Y | 1 |
| Ohtomo, K | 1 |
| Nagai, R | 1 |
1 other study available for carvedilol and Arrhythmogenic Right Ventricular Dysplasia
| Article | Year |
|---|---|
Carvedilol therapy improved left ventricular function in a patient with arrhythmogenic right ventricular cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Arrhythmogenic Right Ventricular Dysplasia; Carbazoles; Carvedil | 2004 |